Diabetics, advocates react to insulin price reductions
Major pharmaceutical companies have rolled out plans for insulin price reductions. Diabetics and advocates are grateful but skeptical.
Read MoreMajor pharmaceutical companies have rolled out plans for insulin price reductions. Diabetics and advocates are grateful but skeptical.
Read More